Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

About the PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is the independent resource on PCSK9 science and its translation into critically important new treatments to lower low density lipoprotein cholesterol (LDL-C), which promise to transform the prognosis of millions of patients with hypercholesterolaemia (cholesterol disorders), accelerated atherosclerotic vascular heart disease and a high risk of premature cardiovascular (CV) death and disability.
Aims & ObjectivesMission StatementEditorial BoardPartnership & OutreachForthcoming Meetings

Question of the Month

PlayCombination therapy in familial hypercholesterolaemia: what can we gain from novel agents? LDL cholesterol lowering and effects on plaque: what can we learn from INTENSITY-HIGH?
Professor John Chapman

Download Now: New Slide Deck Programme

Previous slide decks focused on landmark studies which used a monoclonal antibody approach to inhibit PCSK9. The next in this series discusses inclisiran, a small interfering RNA therapy, which prevents production of PCSK9 at its primary source in the liver.

Find out more »
Most viewed

Hot Topics

16th Virtual Closed Scientific Expert Meeting of the Editorial Board
Statin intolerance: Do we need a new clinical definition and management strategies?
Ulrich Laufs

Professor Ulrich Laufs provides a European perspective to this question.

Watch now

Paul Thompson

Professor Paul Thompson gives a US perspective to what is needed for research into statin intolerance and statin-associated muscle symptoms.

Watch now

From the Editors

Reducing residual risk: Are cholesterol crystals the next target?

John ChapmanProf John Chapman Pitié-Salpetrière University Hospital, INSERM, Paris France discusses how cholesterol crystals play a crucial role in atherothrombosis, and potential therapeutic options.

Read the report

Related reports:

Cholesterol crystals, plaque stability and ASCVD

INTENSITY-HIGH

ACC.22 - PACMAN delivers

HUYGENS

Meet our Editorial Board

View all our Editorial Board Prof John ChapmanResearch Professor at the University of Pierre and Marie Curie Prof Henry GinsbergDirector, Irving Institute for Clinical and Translational Research Dr Michel FarnierClinician based at Point Medical, Dijon, France Prof Frederick RaalDirector, Carbohydrate & Lipid Metabolism Research Unit Prof Anthony WierzbickiConsultant in Metabolic Medicine/Chemical Pathology